Amit Suresh Khairnar, Ph.D.
Assistant professor, Department of Physiology
correspondence Address:
Kamenice 753/5, 625 00 Brno
e‑mail: |
---|
Total number of publications: 32
2025
-
Glycated α-Synuclein Renders Glial Cell Activation and Induces Degeneration of Dopaminergic Neurons: A Potential Implication for the Development of Parkinson's Disease
ACS Chemical Biology, year: 2025, DOI
-
Chronic DSS-Induced Colitis Exacerbates Parkinson’s Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, year: 2025, volume: 8, edition: 2, DOI
-
Molecular Symphony of Mitophagy: Ubiquitin-Specific Protease-30 as a Maestro for Precision Management of Neurodegenerative Diseases
CNS NEUROSCIENCE & THERAPEUTICS, year: 2025, volume: 31, edition: 1, DOI
2024
-
Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer
Free Radical Biology and Medicine, year: 2024, volume: 220, edition: August 2024, DOI
-
Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson's Disease-like Pathology in Mice
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, year: 2024, volume: 7, edition: 12, DOI
2023
-
Alpha mangostin inhibits proliferation, migration, and invasion of human breast cancer cells via STAT3 inhibition
ADVANCES IN CANCER BIOLOGY-METASTASIS, year: 2023, volume: 7, edition: July 2023, DOI
-
Assessment of metabolic stability and pharmacokinetics by LC-MS/MS and establishment of the safe dose of IMID-2, a novel anticancer molecule under drug discovery
BIOMEDICAL CHROMATOGRAPHY, year: 2023, volume: 37, edition: 6, DOI
-
Association of COVID-19 with Comorbidities: An Update
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, year: 2023, volume: 6, edition: 3, DOI
-
Cell-Engineered Recombinant α-Synuclein: A Gage R&R Validated Protocol
Journal of Proteome Research, year: 2023, volume: 23, edition: 1, DOI
-
Empagliflozin mediated miR-128-3p upregulation promotes differentiation of hypoxic cancer stem-like cells in breast cancer
European Journal of Pharmacology, year: 2023, volume: 943, edition: March 2023, DOI